Atlas Trials

A Single and Multiple Doses Safety, Tolerability, Pharmacokinetics and Food Effect Study of KVD824 in Healthy Volunteers

Clinical trial NCT05178355 · COMPLETED

Trial details

NCT number
NCT05178355
Sponsor
KalVista Pharmaceuticals, Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hereditary Angioedema
Start date
2019-02-12
Primary completion
2019-06-21
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.